Questionable stem-cell treatment case still under investigation – Winnipeg Free Press
Winnipeg Free Press |
Questionable stem–cell treatment case still under investigation
Winnipeg Free Press Regenetek is Broeska's Winnipeg-based company that charged roughly 70 multiple sclerosis and ALS patients from around the world as much as $45,000 to be part of a stem–cell clinical trial at a hospital in India. The stem cell treatment promised … |
